In adults, MLL-r leukemia accounts for approximately 5% of ALL cases (Marchesi et al., 2011) and 5–10% of AML cases (Krivtsov and Armstrong, 2007; Chowdhury and Brady, 2008; Chen and Armstrong, 2015). The gene discussed is KMT2A; the disease is leukemia.